Melanoma is a type of skin cancer that develops from cells called melanocytes. It’s the 5th most common cancer in the UK, with around 16,200 new cases of melanoma in the UK each year.
A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a ‘targeted’ cancer drug.
We’re back for day two of our highlights from this year’s NCRI cancer conference in Liverpool.
We explore new research looking at how antioxidants and free radicals might affect the ability of melanoma cells to spread around the body.
We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading.
Our researchers have made an unexpected connection between the biological processes involved in nerve repair and the way some cancers spread.
We explore our latest report showing that thousands of cancer patients are missing out on genetic tests for targeted cancer drugs.
From the mechanics behind fast-moving melanoma cells to cancer’s very own family tree, here are 5 hot research topics our scientists are working on.